Current Science

Open Access Open Access  Restricted Access Subscription Access

Pharmaceutical Patenting Trends on Drugs and Lifestyle Diseases:An Analysis of Indian and Global Status


Affiliations
1 Intellectual Property and Technology Management Unit, Indian Council of Agricultural Research, New Delhi 110 012, India
2 Institute Technology Management Unit, Central Marine Fisheries Research Institute, Ernakulam North PO, P. B. No. 1603, Cochin 682 018, India
 

The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry in India. There is a serious decline in the number of pharma patents recently after compulsory licensing for drugs was implemented in India. While regulations are meant for reducing the prices of essential drugs, there are investment-related issues when a patent is subjected to voluntary licensing. The present study focuses on three phases in pharmaceutical patenting identified by analysing the major patent databases and the potential shift in pharma patenting sector from acute to lifestyle disease-based drugs. The recent trend identified in the pharma patenting sector in India is quite unusual and unreported so far.

Keywords

Compulsory Licensing, Generic Drug Market, Indian Pharma Market, Lifestyle Diseases, Pharma Patenting Trends.
User
Notifications
Font Size

  • Global Pharmaceutical Market Outlook: 2015, Express Pharma, 2012; http://archivepharma.financialexpress.com/20120115/market02.shtml

  • Arun, S., Government to hold talks with WIPO. The Hindu, 15 January 2016, p. 6.

  • Global pharma looks to India: Prospects for growth, PricewaterhouseCoopers, http://www.pwc.com/gx/en/pharma-life-sciences/pdf/global-pharma-looks-to-india.pdf

  • Vidya, K. and Arun, S., India may cease to be ‘pharmacy of the world’, The Hindu, 22 January 2016; http://www.thehindu.com/todays-paper/tp-national/india-may-cease-to-be-pharmacy-of-the-world/article8136978.ece

  • Michael, M., WTO Reviews India’s Trade Policies, Including Drug Patents, Compulsory Licensing, 2015; http://www.raps.org/Regulatory-Focus/News/2015/06/03/22617/WTO-Reviews-Indias-Trade-Policies-Including-Drug-Patents-Compulsory-Licensing/

  • Unnikrishnan, C. H., Compulsory licences may spur more voluntary licensing deals; livemint, 2013; http://www.livemint.com/Home Page/f0R9060osU7bENFNwlnx5O/Compulsory-licences-may-spur-more-voluntary-licensing-deals.html

  • Sushmi, D., 25% of Indians may die of lifestyle diseases before they are 70, The Times of India, 13 August 2015; http://times ofindia.indiatimes.com/india/25-of-Indians-may-die-of-lifestyle-diseases-before-they-are-70-Study/articleshow/48460601.cms

  • Martin, P., Vikram, P., Shekhar, S., Mario, M., Joanna, M., Michael, R. P. and Atif, R., No health without mental health. The Lancet, 2007, 370(9590), 859–877.

  • Pharmaceutical Market India 2014–2020, Formulations, active pharmaceutical ingredients (APIs), contract research and manufacturing services (CRAMS), biosimilars, generics and vaccines, Kelly Scientific Publications, 2014, p. 13.

  • Matthew, H., The Cancer Drug Market Just Hit $100 Billion and Could Jump 50% In Four Years, Forbes, 2015; http://www.forbes.com/sites/matthewherper/2015/05/05/cancer-drug-sales-approach-100-billion-and-could-increase-50-by-2018/#7227004670f4

  • Asia Oncology Drug Market Outlook to 2019 – Driven by Rising Demand and Intensifying Joint Ventures between Companies, PRNewswire, 2015; http://www.prnewswire.com/news-releases/asia-oncology-drug-market-outlook-to-2019---driven-by-rising-demand-and-intensifying-joint-ventures-between-companies-300175417.html

  • Antidiabetics market analysis by product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) and segment forecasts to 2020, Grand View Research, 2015; http://www.grandviewresearch.com/industry-analysis/antidiabetics-market

  • Pharmaceuticals, Indian Brand Equity Foundation, 2016, p. 12; http://www.ibef.org/download/Pharmaceutical-January-2016.pdf

  • Rupali, M., Anti-diabetic drug tops India’s pharma sales. The Times of India, 18 June 2014; http://timesofindia.indiatimes.com/business/india-business/Anti-diabetic-drug-tops-Indias-pharma-sales/articleshow/36731810.cms

  • Cadalmin antidiabetic extract – CadalminM ADe, CMFRI – eprints, 2015, http://eprints.cmfri.org.in/10483/1/Cadalmin_AD_extract.pdf

  • Onkar, S. and Sufiyan, H., World anti-inflammatory therapeutics market – opportunities and forecasts, 2014–2020, Allied Market Research Report, 2015; https://www.alliedmarketresearch.com/anti-inflammatory-therapeutics-market

  • Kajal, C., Intellectual property rights: a perspective in marine fisheries and mariculture, CMFRI Special Publication, 2013, 108, 72–73.

  • Global Hypertension drugs market 2014–2018, Research and markets report, 2014; http://www.researchandmarkets.com/reports/2814392/global-hypertension-drugs-market-2014-2018

  • Thyroid gland disorders treatment market – global industry analysis, size, share, growth, trends and forecast 2015–2023, Transparency Market Research Press Release, 2015; http://www.transparencymarketresearch.com/thyroid-gland-disorder-market.html

  • Rajnish, N., Shirsendu, R., Mohammad, A., Vijay, P., Nayana, K. and Prakash, P., Incidence of thyroid disorders in India: an institutional retrospective analysis. Int. J. Dental Med. Speciality, 2015, 2(2), 19–23.


Abstract Views: 231

PDF Views: 107




  • Pharmaceutical Patenting Trends on Drugs and Lifestyle Diseases:An Analysis of Indian and Global Status

Abstract Views: 231  |  PDF Views: 107

Authors

Vikram Singh
Intellectual Property and Technology Management Unit, Indian Council of Agricultural Research, New Delhi 110 012, India
Kajal Chakraborty
Institute Technology Management Unit, Central Marine Fisheries Research Institute, Ernakulam North PO, P. B. No. 1603, Cochin 682 018, India
Lavina Vincent
Institute Technology Management Unit, Central Marine Fisheries Research Institute, Ernakulam North PO, P. B. No. 1603, Cochin 682 018, India

Abstract


The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry in India. There is a serious decline in the number of pharma patents recently after compulsory licensing for drugs was implemented in India. While regulations are meant for reducing the prices of essential drugs, there are investment-related issues when a patent is subjected to voluntary licensing. The present study focuses on three phases in pharmaceutical patenting identified by analysing the major patent databases and the potential shift in pharma patenting sector from acute to lifestyle disease-based drugs. The recent trend identified in the pharma patenting sector in India is quite unusual and unreported so far.

Keywords


Compulsory Licensing, Generic Drug Market, Indian Pharma Market, Lifestyle Diseases, Pharma Patenting Trends.

References





DOI: https://doi.org/10.18520/cs%2Fv113%2Fi04%2F725-732